12 Heart Attack Clinical Trials in Milwaukee, WI (2026)

Q: How do I join a clinical trial in Milwaukee?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Milwaukee research site will contact you.

Recruiting Heart Attack Studies in Milwaukee

NCT06370520Recruiting

Screening Emotions in Adolescents at the Hospital for mTBI

The goal of this observational study is to develop and validate a clinical tool to predict which adolescents aged 11 to less than 18 years of age with mild traumatic brain injury (mTBI) are at an incr...

Milwaukee, WI2,592 participantsUniversity of California, Davis

View Study Details

NCT07227155Recruiting

The HOPE Biobank Resource (BMT CTN 2402 HOPE)

A prospective, multicenter study that will establish a repository of biospecimens and clinical data from patients undergoing hematopoietic stem cell transplant (HCT) or gene therapy (GT) for treatment...

Milwaukee, WI375 participantsMedical College of Wisconsin

View Study Details

NCT04877522Recruiting

Asciminib Roll-over Study

This is a long term safety study for patients who have completed a Novartis sponsored asciminib study and are judged by the investigator to benefit from continued treatment...

Milwaukee, WIPHASE4347 participantsNovartis Pharmaceuticals

View Study Details

NCT06788639Recruiting

A Study of Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Treated With Lisocabtagene Maraleucel in the Post-Marketing Setting

The purpose of this study is to characterize the long-term safety of lisocabtagene maraleucel (liso-cel), focusing on patients treated in the chronic lymphocytic leukemia (CLL) or small lymphocytic ly...

Milwaukee, WI300 participantsJuno Therapeutics, Inc., a Bristol-Myers Squibb Company

View Study Details

NCT07117136Recruiting

Blinatumomab Consolidation in Real World

This will be a multi-center registry for patients with B-ALL. Patient data will be collected both retrospectively and prospectively. The data forms and surveys will be built and managed through REDCap...

Milwaukee, WI200 participantsMedical College of Wisconsin

View Study Details

NCT04014374Recruiting

Post-authorization Safety Study of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Treated With Mogamulizumab

This is a non-interventional cohort study evaluating non-relapse mortality and toxicities in patients with CTCL or ATLL treated with mogamulizumab pre- or post- alloHCT for patients transplanted begin...

Milwaukee, WI150 participantsKyowa Kirin, Inc.

View Study Details

NCT05143840Recruiting

Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase

This study is a multicenter Phase 2, non-randomized, open-label single-group frontline study administering asciminib in patients with newly diagnosed Chronic Myeloid Leukemia-Chronic Phase (CML-CP). T...

Milwaukee, WIPHASE2100 participantsAugusta University

View Study Details

NCT06707493Recruiting

Ivosidenib as Post-HSCT Maintenance for AML

This is a Phase 2 study of the study drug, ivosidenib (a mutant IDH1 inhibitor), compared to placebo, given to patients with IDH1-mutant acute myeloid leukemia (AML) after hematopoietic stem cell tran...

Milwaukee, WIPHASE275 participantsMassachusetts General Hospital

View Study Details

NCT04838041Recruiting

Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation

This is a single arm phase II study that will enroll a minimum of 47 subjects with a maximum of 51. All patients will have a confirmed diagnosis of chronic phase chronic myeloid Leukemia and must have...

Milwaukee, WIPHASE251 participantsMedical College of Wisconsin

View Study Details

NCT05794880Recruiting

MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing

This is a single arm pilot study for patients with hematologic malignancies receiving unrelated or haploidentical related mobilized peripheral stem cells (PSCs) using the CliniMACS system for alpha/be...

Milwaukee, WINA40 participantsMedical College of Wisconsin

View Study Details

NCT06430788Recruiting

A Study of Emapalumab for Pediatric Aplastic Anemia

The purpose of this study is to find out whether upfront emapalumab treatment can help in sAA (Aplastic Anemia) treatment planning and increase the effectiveness of standard treatment options. Fundin...

Milwaukee, WIPHASE235 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT04746209Recruiting

Blinatumomab After TCR Alpha Beta/CD19 Depleted HCT

This trial will assess the feasibility of alpha/beta T-cell and B-cell depleted allogeneic hematopoietic cell transplantation (HCT) followed by blinatumomab therapy for high-risk B cell acute lymphobl...

Milwaukee, WIPHASE225 participantsMedical College of Wisconsin

View Study Details

About Heart Attack Clinical Trials in Milwaukee

A heart attack (myocardial infarction) occurs when blood flow to part of the heart muscle is blocked, usually by a blood clot. It is a medical emergency requiring immediate treatment. Long-term management includes medications, lifestyle changes, and cardiac rehabilitation.

There are currently 12 heart attack clinical trials recruiting participants in Milwaukee, WI. These studies are seeking a combined 4,290 participants. Research is being sponsored by University of California, Davis, Medical College of Wisconsin, Novartis Pharmaceuticals and 5 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Heart Attack Clinical Trials in Milwaukee — FAQ

Are there heart attack clinical trials in Milwaukee?

Yes, there are 12 heart attack clinical trials currently recruiting in Milwaukee, WI. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Milwaukee?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Milwaukee research site will contact you about next steps.

Are clinical trials in Milwaukee free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Milwaukee studies also compensate for your time and travel.

What heart attack treatments are being tested?

The 12 active trials in Milwaukee are testing new therapies including novel drugs, biologics, and treatment approaches for heart attack.

Data updated July 17, 2026 from ClinicalTrials.gov